Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alaunos Therapeutics (DE:WEK)
FRANKFURT:WEK
Holding DE:WEK?
Track your performance easily
WEK Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€1.00 - €1.01
Previous Close€1
Volume0.00
Average Volume (3M)N/A
Market Cap
€34.58M
Enterprise Value€24.57M
Total Cash (Recent Filing)$11.94M
Total Debt (Recent Filing)$1.17M
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Mar 05, 2024EPS Estimate
-€0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding240,627,055
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)23.50
Price to Sales (P/S)-30844.01
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-3.51K
Enterprise Value/Gross Profit8.47
Enterprise Value/Ebitda-0.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Alaunos Therapeutics News
PremiumCompany Announcements
Alaunos Therapeutics Announces 1-for-15 Reverse Stock Split
PremiumPre-Earnings
Is TCRT a Buy, Before Earnings?
WEK FAQ
What was Alaunos Therapeutics’s price range in the past 12 months?
Alaunos Therapeutics lowest stock price was €0.99 and its highest was €1.01 in the past 12 months.
What is Alaunos Therapeutics’s market cap?
Currently, no data Available
When is Alaunos Therapeutics’s upcoming earnings report date?
Alaunos Therapeutics’s upcoming earnings report date is Mar 05, 2024 which is 292 days ago.
How were Alaunos Therapeutics’s earnings last quarter?
Alaunos Therapeutics released its earnings results on Nov 14, 2023. The company reported -€0.557 earnings per share for the quarter, missing the consensus estimate of -€0.488 by -€0.07.
Is Alaunos Therapeutics overvalued?
According to Wall Street analysts Alaunos Therapeutics’s price is currently Overvalued.
Does Alaunos Therapeutics pay dividends?
Alaunos Therapeutics does not currently pay dividends.
What is Alaunos Therapeutics’s EPS estimate?
Alaunos Therapeutics’s EPS estimate is -€0.42.
How many shares outstanding does Alaunos Therapeutics have?
Currently, no data Available
What happened to Alaunos Therapeutics’s price movement after its last earnings report?
Alaunos Therapeutics reported an EPS of -€0.557 in its last earnings report, missing expectations of -€0.488. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Alaunos Therapeutics?
Among the largest hedge funds holding Alaunos Therapeutics’s share is Discovery Capital Management, LLC. It holds Alaunos Therapeutics’s shares valued at 2M.
---
Alaunos Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DE:WEK Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-77.02%
12-Months-Change
Fundamentals
Return on Equity
-158.46%
Trailing 12-Months
Asset Growth
-71.13%
Trailing 12-Months
Company Description
Alaunos Therapeutics
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA.
---
WEK Earnings Call
Q1 2023
0:00 / 0:00
---
WEK Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Gritstone Oncology
―
Kintara Therapeutics
―
XBiotech
―
Galectin Therapeutics
―
Alaunos Therapeutics
―
Best Analysts Covering WEK
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-83.50%
reiterated a buy rating 2 years ago
Copying James Shin's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -83.50% per trade.
---